Key Findings

The study identifies several mechanisms by which Pseudomonas aeruginosa can reduce susceptibility to the LpxC inhibitor CHIR-090, including mutations in efflux pump regulators (mexR, nfxB, mexS), overexpression of LpxC, and mutations in the fatty acid biosynthesis gene fabG.